Skip to main content
Erschienen in: Supportive Care in Cancer 12/2016

27.07.2016 | Original Article

“Melanoma: Questions and Answers.” Development and evaluation of a psycho-educational resource for people with a history of melanoma

verfasst von: Nadine A. Kasparian, Shab Mireskandari, Phyllis N. Butow, Mbathio Dieng, Anne E. Cust, Bettina Meiser, Kristine Barlow-Stewart, Scott Menzies, Graham J. Mann

Erschienen in: Supportive Care in Cancer | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

People with melanoma often report pervasive fears about cancer recurrence, unmet information needs, and difficulties accessing psychological care. Interventions addressing the supportive care needs of people with melanoma are rare, and needs are often overlooked. The study evaluated a newly developed, evidence-based, psycho-educational resource for people with melanoma.

Methods

The evaluation study comprised three groups: adults at high risk of new primary disease due to multiple previous melanomas or one melanoma and dysplastic nevus syndrome (DNS), adults at moderate risk due to one previous melanoma and no DNS, and health professionals involved in melanoma care. Participants evaluated a 68-page psycho-educational booklet, Melanoma: Questions and Answers, developed by a multidisciplinary team in accordance with published evidence, clinical guidelines, and intervention development frameworks. The booklet comprised seven modules featuring information on melanoma diagnosis, treatment, prognosis, and ongoing clinical management; risk factors and the role of genetic counseling services for melanoma; psycho-education on emotional, behavioral, and cognitive responses to melanoma, including psycho-education on fear of cancer recurrence; description of healthy coping responses; a suite of tailored tools to support skin self-examination, doctor-patient communication, and identification of the signs and symptoms of anxiety and depression; a list of community-based services and resources; and tools to support melanoma-related record keeping and monitoring. Resource acceptability, relevance, quality, dissemination preferences, emotional responses, unmet information needs, and demographic characteristics were assessed.

Results

Nineteen melanoma survivors (response rate 50 %) and 10 health professionals (response rate 83 %) evaluated the resource. Responses were overwhelmingly positive; the booklet was thoroughly read and highly rated in terms of quality and quantity of information, utility of health education tools, and capacity to address unmet needs. Ninety-five percent of melanoma survivors would recommend the booklet to others. Most preferred a paper-based format, provided by their treating doctor at diagnosis.

Conclusions

Melanoma: Questions and Answers was feasible and acceptable and demonstrated a strong capacity to address the information and psycho-educational needs of people with melanoma at low fiscal cost.
Literatur
3.
5.
Zurück zum Zitat Whiteman D, Watt P, Purdie D, Hughes M, Hayward N, Green A (2003) Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 95(11):806–812CrossRefPubMed Whiteman D, Watt P, Purdie D, Hughes M, Hayward N, Green A (2003) Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 95(11):806–812CrossRefPubMed
6.
Zurück zum Zitat Kefford R, Mann G (2003) Is there a role for genetic testing in patients with melanoma? Curr Opin Oncol 15:157–161CrossRefPubMed Kefford R, Mann G (2003) Is there a role for genetic testing in patients with melanoma? Curr Opin Oncol 15:157–161CrossRefPubMed
7.
Zurück zum Zitat Youlden DR, Youl PH, Soyer HP, Aitken JF, Baade PD (2014) Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010. JAMA Dermatol 150:526–534CrossRefPubMed Youlden DR, Youl PH, Soyer HP, Aitken JF, Baade PD (2014) Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010. JAMA Dermatol 150:526–534CrossRefPubMed
8.
Zurück zum Zitat Bradford PT, Freedman DM, Goldstein AM, MA T (2010) Increased risk of second primary cancers after a diagnosis of melanoma. Arch Dermatol 146(3):265–272CrossRefPubMedPubMedCentral Bradford PT, Freedman DM, Goldstein AM, MA T (2010) Increased risk of second primary cancers after a diagnosis of melanoma. Arch Dermatol 146(3):265–272CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Doubrovsky A, Menzies S (2003) Enhanced survival in patients with multiple primary melanoma. Arch Dermatol 139:1013–1018CrossRefPubMed Doubrovsky A, Menzies S (2003) Enhanced survival in patients with multiple primary melanoma. Arch Dermatol 139:1013–1018CrossRefPubMed
10.
Zurück zum Zitat Sollner W, Zingg-Schir M, Rumpold G, Mairinger G, Fritsch P (1998) Need for supportive counselling—the professionals’ versus the patients’ perspective: a survey in a representative sample of 236 melanoma patients. Psychother Psychosom 67(2):94–104CrossRefPubMed Sollner W, Zingg-Schir M, Rumpold G, Mairinger G, Fritsch P (1998) Need for supportive counselling—the professionals’ versus the patients’ perspective: a survey in a representative sample of 236 melanoma patients. Psychother Psychosom 67(2):94–104CrossRefPubMed
11.
Zurück zum Zitat McLoone J, Watts K, Menzies S, Meiser B, Butow P, Kasparian N (2012) When the risks are high: psychological adjustment among melanoma survivors at high risk of developing new primary disease. Qual Health Res 22(8):1102–1113CrossRefPubMed McLoone J, Watts K, Menzies S, Meiser B, Butow P, Kasparian N (2012) When the risks are high: psychological adjustment among melanoma survivors at high risk of developing new primary disease. Qual Health Res 22(8):1102–1113CrossRefPubMed
12.
Zurück zum Zitat Costa DSJ, Dieng M, Cust AE, Butow PN, NA K (2015) Psychometric properties of the fear of cancer recurrence inventory: an item response theory approach. Psycho-Oncol (in press) Costa DSJ, Dieng M, Cust AE, Butow PN, NA K (2015) Psychometric properties of the fear of cancer recurrence inventory: an item response theory approach. Psycho-Oncol (in press)
13.
Zurück zum Zitat Kasparian NA (2013) Psychological care for people with melanoma: what, when, why and how? Semin Oncol Nurs 29(3):214–222CrossRefPubMed Kasparian NA (2013) Psychological care for people with melanoma: what, when, why and how? Semin Oncol Nurs 29(3):214–222CrossRefPubMed
14.
Zurück zum Zitat Schofield P, Carey M, Bonevski B, Sanson-Fisher R (2006) Barriers to the provision of evidence-based psychosocial care in oncology. Psycho-Oncol 15(10):863–872CrossRef Schofield P, Carey M, Bonevski B, Sanson-Fisher R (2006) Barriers to the provision of evidence-based psychosocial care in oncology. Psycho-Oncol 15(10):863–872CrossRef
15.
Zurück zum Zitat Loquai C, Scheurich V, Syring N, et al. (2013) Screening for distress in routine oncological care: a survey in 520 melanoma patients. PLoS One 8(7):e66800CrossRefPubMedPubMedCentral Loquai C, Scheurich V, Syring N, et al. (2013) Screening for distress in routine oncological care: a survey in 520 melanoma patients. PLoS One 8(7):e66800CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Australian Cancer Network (2008) Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand. Canberra: National Health and Medical Research Council (NHMRC) Australian Cancer Network (2008) Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand. Canberra: National Health and Medical Research Council (NHMRC)
17.
Zurück zum Zitat Bares CB, Trask PC, Schwartz SM (2002) An exercise in cost-effectiveness analysis: treating emotional distress in melanoma patients. J Clin Psychol Med Settings 9(3):193–200CrossRef Bares CB, Trask PC, Schwartz SM (2002) An exercise in cost-effectiveness analysis: treating emotional distress in melanoma patients. J Clin Psychol Med Settings 9(3):193–200CrossRef
18.
Zurück zum Zitat McLoone J, Menzies S, Meiser B, Mann G, Kasparian N (2013) Psycho-educational interventions for people affected by melanoma: a systematic review. Psycho-Oncol 22:1444–1456CrossRef McLoone J, Menzies S, Meiser B, Mann G, Kasparian N (2013) Psycho-educational interventions for people affected by melanoma: a systematic review. Psycho-Oncol 22:1444–1456CrossRef
19.
Zurück zum Zitat Foot G, Sanson-Fisher R (1995) Measuring unmet needs of people living with cancer. Cancer Forum 19(2):131–135 Foot G, Sanson-Fisher R (1995) Measuring unmet needs of people living with cancer. Cancer Forum 19(2):131–135
20.
Zurück zum Zitat Bonevski B, Sanson-Fisher R, Hersey P, Paul C, Foot G (1999) Assessing the perceived needs of patients attending an outpatient melanoma clinic. J Psychosoc Oncol 17(3–4):101–118 Bonevski B, Sanson-Fisher R, Hersey P, Paul C, Foot G (1999) Assessing the perceived needs of patients attending an outpatient melanoma clinic. J Psychosoc Oncol 17(3–4):101–118
21.
Zurück zum Zitat Fallowfield L, Hall A, Maguire P, Baum M, A’Hern R (1994) Psychological effects of being offered choice of surgery for breast cancer. Br Med J 309:448CrossRef Fallowfield L, Hall A, Maguire P, Baum M, A’Hern R (1994) Psychological effects of being offered choice of surgery for breast cancer. Br Med J 309:448CrossRef
22.
Zurück zum Zitat Brandberg Y, Bergenmar M, Bolund C, Michelson H, et al. (1994) Information to patients with malignant melanoma: a randomized group study. Patient Educ Couns 23(2):97–105CrossRefPubMed Brandberg Y, Bergenmar M, Bolund C, Michelson H, et al. (1994) Information to patients with malignant melanoma: a randomized group study. Patient Educ Couns 23(2):97–105CrossRefPubMed
23.
Zurück zum Zitat Kasparian NA, McLoone JK, Meiser B, Butow PN, Simpson JM, GJ M (2010) Skin cancer screening behaviours among individuals with a strong family history of malignant melanoma. Br J Cancer 103:1502–1509CrossRefPubMedPubMedCentral Kasparian NA, McLoone JK, Meiser B, Butow PN, Simpson JM, GJ M (2010) Skin cancer screening behaviours among individuals with a strong family history of malignant melanoma. Br J Cancer 103:1502–1509CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat McLoone J, Watts K, Menzies S, Barlow-Stewart K, Mann G, Kasparian N (2013) Melanoma survivors at high risk of developing new primary disease: a qualitative examination of the factors that contribute to patient satisfaction with clinical care. Psycho-Oncol 22(9):1994–2000CrossRef McLoone J, Watts K, Menzies S, Barlow-Stewart K, Mann G, Kasparian N (2013) Melanoma survivors at high risk of developing new primary disease: a qualitative examination of the factors that contribute to patient satisfaction with clinical care. Psycho-Oncol 22(9):1994–2000CrossRef
25.
Zurück zum Zitat Medical Research Council. Developing and evaluating complex interventions: new guidance. London: Medical Research Council;2006. Medical Research Council. Developing and evaluating complex interventions: new guidance. London: Medical Research Council;2006.
26.
Zurück zum Zitat Lazarus R, Folkman S (1984) Stress, appraisal, and coping. Springer, New York Lazarus R, Folkman S (1984) Stress, appraisal, and coping. Springer, New York
27.
28.
Zurück zum Zitat National Breast Cancer Centre and National Cancer Control Initiative (2003) Clinical practice guidelines for the psychosocial care of adults with cancer. National Breast Cancer Centre, Camperdown, NSW National Breast Cancer Centre and National Cancer Control Initiative (2003) Clinical practice guidelines for the psychosocial care of adults with cancer. National Breast Cancer Centre, Camperdown, NSW
29.
Zurück zum Zitat National Health and Medical Research Council (2000) How to present the evidence for consumers: preparation of consumer publications. Canberra: Commonwealth of Australia National Health and Medical Research Council (2000) How to present the evidence for consumers: preparation of consumer publications. Canberra: Commonwealth of Australia
30.
Zurück zum Zitat Dimoska A, Tattersall MH, Butow PN, Shepherd H, Kinnersley P (2008) Can a “prompt list” empower cancer patients to ask relevant questions? Cancer 113(2):225–237CrossRefPubMed Dimoska A, Tattersall MH, Butow PN, Shepherd H, Kinnersley P (2008) Can a “prompt list” empower cancer patients to ask relevant questions? Cancer 113(2):225–237CrossRefPubMed
31.
Zurück zum Zitat Kasparian N, Butow P, Meiser B, Mann G (2008) High- and average-risk individuals’ beliefs about, and perceptions of, malignant melanoma: an Australian perspective. Psycho-Oncol 17(3):270–279CrossRef Kasparian N, Butow P, Meiser B, Mann G (2008) High- and average-risk individuals’ beliefs about, and perceptions of, malignant melanoma: an Australian perspective. Psycho-Oncol 17(3):270–279CrossRef
32.
Zurück zum Zitat Australian Bureau of Statistics (2012) Year Book Australia, 2012. Canberra: Australian Bureau of Statistics Australian Bureau of Statistics (2012) Year Book Australia, 2012. Canberra: Australian Bureau of Statistics
34.
Zurück zum Zitat Hodgkinson K, Butow P, Hunt G, et al. (2007) The development and evaluation of a measure to assess cancer survivors’ unmet supportive care needs: the CaSUN (cancer survivors’ unmet needs measure). Psycho-Oncol 16:796–804CrossRef Hodgkinson K, Butow P, Hunt G, et al. (2007) The development and evaluation of a measure to assess cancer survivors’ unmet supportive care needs: the CaSUN (cancer survivors’ unmet needs measure). Psycho-Oncol 16:796–804CrossRef
35.
Zurück zum Zitat Simard S, Savard J (2009) Fear of cancer recurrence inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer 17(3):241–251CrossRefPubMed Simard S, Savard J (2009) Fear of cancer recurrence inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer 17(3):241–251CrossRefPubMed
36.
Zurück zum Zitat Simard S, Savard J Screening and comorbidity of clinical levels of fear of cancer recurrence. J. Cancer Survivorship (in press) Simard S, Savard J Screening and comorbidity of clinical levels of fear of cancer recurrence. J. Cancer Survivorship (in press)
37.
Zurück zum Zitat Zigmond A, Snaith R (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMed Zigmond A, Snaith R (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMed
38.
Zurück zum Zitat Khoo K, Bolt P, Babl FE, Jury S, Goldman RD (2008) Health information seeking by parents in the internet age. J Paediatr Child Health 44(7–8):419–423CrossRefPubMed Khoo K, Bolt P, Babl FE, Jury S, Goldman RD (2008) Health information seeking by parents in the internet age. J Paediatr Child Health 44(7–8):419–423CrossRefPubMed
39.
Zurück zum Zitat Carlson LE (2016) Mindfulness-based interventions for coping with cancer. Ann N Y Acad Sci (in press) Carlson LE (2016) Mindfulness-based interventions for coping with cancer. Ann N Y Acad Sci (in press)
40.
Zurück zum Zitat Janda M, Youl P, Neale R, et al. (2014) Clinical skin examination outcomes after a video-based behavioral intervention: analysis from a randomized clinical trial. JAMA Dermatol 150(4):372–379CrossRefPubMed Janda M, Youl P, Neale R, et al. (2014) Clinical skin examination outcomes after a video-based behavioral intervention: analysis from a randomized clinical trial. JAMA Dermatol 150(4):372–379CrossRefPubMed
41.
Zurück zum Zitat Djaja N, Youl P, Aitken J, Janda M (2014) Evaluation of a skin self-examination attitude scale using an item response theory model approach. Health Qual Life Outcomes 12:189CrossRefPubMedPubMedCentral Djaja N, Youl P, Aitken J, Janda M (2014) Evaluation of a skin self-examination attitude scale using an item response theory model approach. Health Qual Life Outcomes 12:189CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Dieng M, Kasparian NA, Butow PN, et al. (2015) Protocol of a randomised controlled trial of a psycho-educational intervention for melanoma survivors at high risk of developing new primary disease. BMC Psychol 3(1):23CrossRefPubMedPubMedCentral Dieng M, Kasparian NA, Butow PN, et al. (2015) Protocol of a randomised controlled trial of a psycho-educational intervention for melanoma survivors at high risk of developing new primary disease. BMC Psychol 3(1):23CrossRefPubMedPubMedCentral
Metadaten
Titel
“Melanoma: Questions and Answers.” Development and evaluation of a psycho-educational resource for people with a history of melanoma
verfasst von
Nadine A. Kasparian
Shab Mireskandari
Phyllis N. Butow
Mbathio Dieng
Anne E. Cust
Bettina Meiser
Kristine Barlow-Stewart
Scott Menzies
Graham J. Mann
Publikationsdatum
27.07.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 12/2016
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3339-3

Weitere Artikel der Ausgabe 12/2016

Supportive Care in Cancer 12/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.